Increased intraabdominal adipose tissue mass in fructose fed rats: Correction by metformin

Experimental and Clinical Endocrinology and Diabetes

Volumn 110, Issue 6, 2002, Pages 298-303

  Baret, G ^a   Peyronnet, J ^a   Grassi Kassisse, D ^a   Dalmaz, Y ^a   Wiernsperger, N ^a   Geloen A ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Adipose tissue; Fructose; Hyperinsulinemic euglycemic clamp; Insulin resistance; Sympathetic nervous system

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; DOPA; DOPA DECARBOXYLASE INHIBITOR; DRINKING WATER; FRUCTOSE; INSULIN; METFORMIN; NEUTRAL INSULIN; ANTIDIABETIC AGENT;

ABDOMEN; ADIPOSE TISSUE; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; WHITE ADIPOSE TISSUE; ANIMAL; DIET; DRUG EFFECT; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ANIMALS; DIET; FRUCTOSE; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; METFORMIN; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC NERVOUS SYSTEM;

EID: 0036710674     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34593     Document Type: Article

References (23)

1. Abbasi F, Kamath V, Rizvi AA, Carantoni M, Chen YD, Reaven GM. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-rteated patients. Evidence for a central role of adipose tissue. Diabetes Care 1997; 20: 1863-1869
2. Abbasi F, Carantoni M, Chen YD, Reaven GM. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diabetes Care 1999; 22: 179-180
3. Bartness TJ. Bamshad M. Innervation of mammalian white adipose tissue: Implications for the regulation of total body fat. Am J Physiol 1998; 275: R1399-R1411
4. Blouquit MF, Géloën A, Koubi H, Edwards D, Gripois D. Decreased norepinephrine turnover rate in the brown adipose tissue of pre-obese fa/fa Zucker rats. J Dev Physiol 1993; 19: 247-251
5. Bunnag P, Hori MT, Ormsby B, Berger ME, Golub MS, Tuck ML. Impaired in vivo adrenergic responses in diet-induced hypertensive rats. Hypertens Res 1997; 20: 17-21
6. Fontbonne A, Charles MA. Juhan-Vague I, Bard JM, Andre P, Isnard F, Cohen JM, Grandmottet P, Vague P, Safar ME, Eschwege E. The effect of metformin on the metabolic abnormalilties associated with upperbody fat distribution. BIGPRO Study Group Diabetes Care 1996; 19: 920-926
7. Grodsky GM, Ma YH, Edwards RH. Chronic sympathetic innervation of islets in transgenic mice results in differential desensitization of alpha-adrenergic inhibition of insulin secretion. Adv Exp Med Biol 1997; 426: 129-138
8. Gudbjornsdottir S, Friberg P, Elam M. Attvall S, Lonroth P, Wallin BG. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant normoglycemic, hypertensive men. Blood Press 1994; 3: 394-403
9. Klepser TB, Kelly MW. Metformin hydrochloride: An antihyperglycemic agent. Am J Health Syst Pharm 1997; 15: 893-903
10. Kraegen EW, James DE, Bennett SP, Chisholm DJ. In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am J Physiol 1983; 245: E1-E7
11. Lee MK, Miles PDG, Khoursheed M, Gao KM, Moossa AR. Olefsky JM. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 1994; 43: 1435-1439
12. Muntzel MS, Petersen JS. Effects of adrenergic, cholinergic and ganglionic blockade on acute depressor reponses to metformin in spontaneously hypertensive rats. J Pharmacol Exp Ther 281 (2): 618-623, 1997
13. Niijima A. Effect of glucose and other hexoses on efferent discharges of brown adipose tissue nerves. Am J Physiol 1986; 251: R240-2
14. Pénicaud L, Berthaud MF, Morin J, Dubar M, Ktorza A, Ferré P. Rilmenidine normalizes fructose-induced resistance and hytpertension in rats. J Hypertens 16 Suppl 1998; S45-S49
15. Perriello G, Misericordia P, Volpi E, Santucci A, Ferrannini E, Ventura MM, Santeusanio F, Brunetti P, Bolli GB. Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 1994; 43: 920-8
16. Radziuk J, Zhang Z, Wiernsperger N, Pye S. Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver. Diabetes 1997; 46: 1406-1413
17. Rosen P, Ohly P, Gleichmann H. Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose-fed rat. J Hypertens 15 Suppl 1997; S31-S38
18. Schwarz JM, J. Acheson K, Tappy L, Piolino V, Muller MJ, Felber JP, Jequier E. Thermogenesis and fructose metabolism in humans. Am J Physiol 1992; 262: E591-E598
19. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 1989; 49: 1155-1163
20. Tobey TA, Mondon CE, Zavaroni 1, Reaven GM. Mechanism of insulin resistance in fructose-fed rats. Metabolism 1982; 31: 608-612
21. Van De Borne P, Hausberg M, Hoofman RP, Anderson EA. Hypersinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am J Physiol 1999; 276: R178-R183
22. Walgren MC, Young JB, Kaufman LN, Landsberg L. The effects of various carbohydrates on sympathetic activity in heart and interscapular brown adipose tissue of the rat. Metabolism 1987; 36: 585-594
23. Zavaroni I, Sander S, Scott S, Reaven GM. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 1980; 29: 970-973